173 related articles for article (PubMed ID: 37101376)
21. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
22. Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice.
Fang X; Huang Z; Zhai K; Huang Q; Tao W; Kim L; Wu Q; Almasan A; Yu JS; Li X; Stark GR; Rich JN; Bao S
Sci Transl Med; 2021 Jun; 13(600):. PubMed ID: 34193614
[TBL] [Abstract][Full Text] [Related]
23. EGFR/FOXO3a/BIM signaling pathway determines chemosensitivity of BMP4-differentiated glioma stem cells to temozolomide.
Ciechomska IA; Gielniewski B; Wojtas B; Kaminska B; Mieczkowski J
Exp Mol Med; 2020 Aug; 52(8):1326-1340. PubMed ID: 32788653
[TBL] [Abstract][Full Text] [Related]
24. CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells.
Lin HW; Chiang YC; Sun NY; Chen YL; Chang CF; Tai YJ; Chen CA; Cheng WF
Endocr Relat Cancer; 2019 Jan; 26(1):73-88. PubMed ID: 30121622
[TBL] [Abstract][Full Text] [Related]
25. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
[TBL] [Abstract][Full Text] [Related]
26. Neuronal Activity Promotes Glioma Progression by Inducing Proneural-to-Mesenchymal Transition in Glioma Stem Cells.
Guo X; Qiu W; Wang C; Qi Y; Li B; Wang S; Zhao R; Cheng B; Han X; Du H; Gao Z; Pan Z; Zhao S; Li G; Xue H
Cancer Res; 2024 Feb; 84(3):372-387. PubMed ID: 37963207
[TBL] [Abstract][Full Text] [Related]
27. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
28. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
29. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
[TBL] [Abstract][Full Text] [Related]
30. Cross-talk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells.
Yin J; Seo Y; Rhim J; Jin X; Kim TH; Kim SS; Hong JH; Gwak HS; Yoo H; Park JB; Kim JH
Cancer Res; 2023 Nov; 83(22):3693-3709. PubMed ID: 37747775
[TBL] [Abstract][Full Text] [Related]
31. Chitinase-3 like-protein-1 promotes glioma progression via the NF-κB signaling pathway and tumor microenvironment reprogramming.
Zhao T; Zeng J; Xu Y; Su Z; Chong Y; Ling T; Xu H; Shi H; Zhu M; Mo Q; Huang X; Li Y; Zhang X; Ni H; You Q
Theranostics; 2022; 12(16):6989-7008. PubMed ID: 36276655
[No Abstract] [Full Text] [Related]
32. Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma.
Tao W; Chu C; Zhou W; Huang Z; Zhai K; Fang X; Huang Q; Zhang A; Wang X; Yu X; Huang H; Wu Q; Sloan AE; Yu JS; Li X; Stark GR; Rich JN; Bao S
Nat Commun; 2020 Jun; 11(1):3015. PubMed ID: 32541784
[TBL] [Abstract][Full Text] [Related]
33. Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis.
Chen X; Hao A; Li X; Du Z; Li H; Wang H; Yang H; Fang Z
J Pineal Res; 2016 Sep; 61(2):208-17. PubMed ID: 27121240
[TBL] [Abstract][Full Text] [Related]
34. Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling.
Lee D; Gimple RC; Wu X; Prager BC; Qiu Z; Wu Q; Daggubati V; Mariappan A; Gopalakrishnan J; Sarkisian MR; Raleigh DR; Rich JN
J Clin Invest; 2023 Jan; 133(2):. PubMed ID: 36394953
[TBL] [Abstract][Full Text] [Related]
35. Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.
Zhang G; Dong Z; Prager BC; Kim LJ; Wu Q; Gimple RC; Wang X; Bao S; Hamerlik P; Rich JN
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30779712
[TBL] [Abstract][Full Text] [Related]
36. Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated Macrophages.
Yuan W; Zhang Q; Gu D; Lu C; Dixit D; Gimple RC; Gao Y; Gao J; Li D; Shan D; Hu L; Li L; Li Y; Ci S; You H; Yan L; Chen K; Zhao N; Xu C; Lan J; Liu D; Zhang J; Shi Z; Wu Q; Yang K; Zhao L; Qiu Z; Lv D; Gao W; Yang H; Lin F; Wang Q; Man J; Li C; Tao W; Agnihotri S; Qian X; Mack SC; Zhang N; You Y; Rich JN; Sun G; Wang X
Clin Cancer Res; 2023 Sep; 29(18):3779-3792. PubMed ID: 37439870
[TBL] [Abstract][Full Text] [Related]
37. Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3.
Guryanova OA; Wu Q; Cheng L; Lathia JD; Huang Z; Yang J; MacSwords J; Eyler CE; McLendon RE; Heddleston JM; Shou W; Hambardzumyan D; Lee J; Hjelmeland AB; Sloan AE; Bredel M; Stark GR; Rich JN; Bao S
Cancer Cell; 2011 Apr; 19(4):498-511. PubMed ID: 21481791
[TBL] [Abstract][Full Text] [Related]
38. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis.
Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS
J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407
[TBL] [Abstract][Full Text] [Related]
39. Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination.
Fang X; Zhou W; Wu Q; Huang Z; Shi Y; Yang K; Chen C; Xie Q; Mack SC; Wang X; Carcaboso AM; Sloan AE; Ouyang G; McLendon RE; Bian XW; Rich JN; Bao S
J Exp Med; 2017 Jan; 214(1):245-267. PubMed ID: 27923907
[TBL] [Abstract][Full Text] [Related]
40. Targeting A20 decreases glioma stem cell survival and tumor growth.
Hjelmeland AB; Wu Q; Wickman S; Eyler C; Heddleston J; Shi Q; Lathia JD; Macswords J; Lee J; McLendon RE; Rich JN
PLoS Biol; 2010 Feb; 8(2):e1000319. PubMed ID: 20186265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
